|
Post by ashiwi on Feb 26, 2014 13:59:27 GMT -5
www.fda.gov/AdvisoryCommittees/Calendar/ucm386716.htm...Public Participation. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before March 18, 2014. Oral presentations from the public will be scheduled between approximately 1:00 p.m. to 2:00 p.m. on April 1, 2014. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before March 10, 2014. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by March 11, 2014... FDA can at least prevent a filibuster by the shorts by screening and limiting a public speaker's allotted time. Hopefully some of the diabetic experts and people like Afrezzauser will make the effort to speak on behalf of MNKD
|
|